Product Information
DARUNAVIR 600 MG TABLET is a generic product labeled by Amneal Pharmaceuticals NY LLC, priced at $1.1628 per EA under NDC 60219114406. Its NADAC has been published 117 times since Jul 10, 2024.
FDA first approved this application on Dec 8, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
600 mg/1
Manufacturer
Amneal Pharmaceuticals NY LLCNDC
60219114406
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DARUNAVIRApproval Type
Generic (ANDA)
FDA Application
ANDA212493FDA Approved
12/8/2023
TE Code
AB
On Market Since
12/9/2023
Pharmacological Classes
Price Statistics
The NADAC for DARUNAVIR 600 MG TABLET has been published 117 times since Jul 10, 2024, and over the history we have for it it has declined 24.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.1628 per EA |
|---|---|
| All-time high | $1.5445 (Jul 10, 2024) |
| All-time low | $1.1309 (Mar 18, 2026) |
| 52-week high | $1.2126 |
| 52-week low | $1.1309 |
| Median price | $1.2126 |
| Average price | $1.2993 |
| Largest weekly change | -7.2% (May 21, 2025) |
| Weeks tracked | 117 |
| Tracking since | Jul 10, 2024 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Amneal Pharmaceuticals NY LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Darunavir market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Protease Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DARUNAVIR 600 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DARUNAVIR 600 MG TABLET, manufactured by Amneal Pharmaceuticals NY LLC, is $1.1628 per EA (NDC 60219114406), effective Sep 30, 2026.
How has the price of DARUNAVIR 600 MG TABLET changed over time?
Over the history we have for it, the NADAC for DARUNAVIR 600 MG TABLET has declined 24.7%. It has been tracked across 117 weekly CMS publications since Jul 10, 2024.
What are the highest and lowest recorded NADAC prices for DARUNAVIR 600 MG TABLET?
Since Jul 10, 2024, the NADAC for DARUNAVIR 600 MG TABLET has ranged from a low of $1.1309 (Mar 18, 2026) to a high of $1.5445 (Jul 10, 2024), with a median of $1.2126 per EA.
Are there cheaper alternatives to DARUNAVIR 600 MG TABLET?
6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DARUNAVIR 600 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures DARUNAVIR 600 MG TABLET?
DARUNAVIR 600 MG TABLET (NDC 60219114406) is labeled by Amneal Pharmaceuticals NY LLC, and CMS classifies it as a generic product.